Markets

Moderna stock surges as melanoma vaccine trial shows "landmark moment"

2 sources ·2 articles ·2h ago

2 outlets - including Cbsnews and Biopharmadive - are covering this story. Moderna and Merck announced study results that reflect a "landmark moment" in treatment for one of the deadliest forms of skin cancer.

Covered by 2 outlets

Cbsnews 1 Biopharmadive 1

All coverage · 2 articles

CBS MoneyWatch ·2h ago

Moderna stock surges as melanoma vaccine trial shows "landmark moment"

Moderna and Merck announced study results that reflect a "landmark moment" in treatment for one of the deadliest forms of skin cancer.

BioPharma Dive ·4h ago

Moderna and Merck cancer vaccine returns ‘landmark’ result in melanoma

At an interim data check, investigators of a key trial found the individualized mRNA treatment kept disease from returning and stopped its spread, sparking a surge in Moderna shares.

Moderna stock surges as melanoma vaccine trial shows "landmark moment"

Moderna stock surges as melanoma vaccine trial shows "landmark moment" →

Moderna and Merck cancer vaccine returns ‘landmark’ result in melanoma →

Moderna stock surges as melanoma vaccine trial shows "landmark moment"

Moderna and Merck cancer vaccine returns ‘landmark’ result in melanoma